Quick Answer
SpyGlass Pharma, Inc. reported Net Income of -$39.87 million for fiscal year 2025.
SpyGlass Pharma, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$39.87M | -36.7% |
| 2024 | -$29.16M | — |
- SpyGlass Pharma, Inc. showed a decrease of -36.7% in Net Income compared to the prior fiscal year.
- Over the 2024–2025 period, SpyGlass Pharma, Inc.’s net income has declined by 36.7% (from -$29.16 million to -$39.87 million).
- The most recent figure is from SpyGlass Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: